Why Are Billionaire Investors Betting On The 2021 Mental Health Revolution?
Investors say this little-known sector feels exactly like CBD did in 2017. This new technology is making investors like Peter Thiel very excited.
See How Early "Mental Health Revolution" Investors

APS Insider Trading (Aptose Biosciences)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$2,618,978.13

Aptose Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Aptose Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aptose Biosciences Share Price & Price History

Current Price: C$4.24
Price Change: Price Increase of +0.1 (2.42%)
As of 06/24/2021 12:00 PM ET

This chart shows the closing price history over time for APS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Why Are Billionaire Investors Betting On The 2021 Mental Health Revolution?
Investors say this little-known sector feels exactly like CBD did in 2017. This new technology is making investors like Peter Thiel very excited.
See How Early "Mental Health Revolution" Investors

Aptose Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/21/2021Warren WhiteheadDirectorSell15,400C$4.15C$63,848.4024,600
12/22/2020Warren WhiteheadDirectorSell10,000C$5.17C$51,745.0050,000
7/10/2020Gregory Kwok Lee ChowSenior OfficerSell126,668C$8.47C$1,072,877.96232,846
7/10/2020William Glenn RiceDirectorSell168,891C$8.47C$1,430,506.77297,523
6/23/2020Warren WhiteheadDirectorSell5,000C$9.69C$48,450.0058,000
10/24/2019William Glenn RiceDirectorBuy10,000C$2.53C$25,344.00163,014
4/18/2019William Glenn RiceDirectorBuy10,000C$2.44C$24,429.24153,014
3/14/2019William Glenn RiceDirectorBuy10,000C$2.51C$25,070.76143,014
10/8/2018William Glenn RiceDirectorBuy10,000C$2.13C$21,300.00
7/16/2018Gregory Kwok Lee ChowInsiderBuy6,000C$3.07C$18,420.00
7/16/2018William Glenn RiceDirectorBuy10,000C$3.11C$31,100.00
See Full Table
Insider Trading at Aptose Biosciences?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aptose Biosciences and related companies.

SEC Filings (Institutional Ownership Changes) for Aptose Biosciences (TSE:APS)

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.
Read More on Aptose Biosciences

Today's Range

Now: C$4.24
Low: C$4.17
High: C$4.26

50 Day Range

MA: C$5.98
Low: C$4.11
High: C$6.90

52 Week Range

Now: C$4.24
Low: C$3.98
High: C$9.40

Volume

13,041 shs

Average Volume

52,898 shs

Market Capitalization

C$377.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aptose Biosciences?

Aptose Biosciences' top insider investors include:
  1. William Glenn Rice (Director)
  2. Gregory Kwok Lee Chow (Senior Officer)
  3. Warren Whitehead (Director)
Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today